YARROW BIOSCIENCE, INC. Amortization of Debt Discount (Premium)
YARROW BIOSCIENCE, INC. (YARW) reported Amortization of Debt Discount (Premium) of -$21.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for the quarter ending 2026-06-30 was -$3.00K.
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for the quarter ending 2026-03-31 was -$18.00K.
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for the quarter ending 2025-06-30 was -$214.00K.
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for the quarter ending 2025-03-31 was -$324.00K.
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for fiscal 2023 was -$255.00K.
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for fiscal 2021 was $1.80M, a 260.00% increase from fiscal 2020.
- YARROW BIOSCIENCE, INC. amortization of debt discount (premium) for fiscal 2020 was $500.00K, a 400.00% increase from fiscal 2019.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 3 month as first filed | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | -$21.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | -$18.00K S-4/A · filed 2026-06-03 | ||||
| 2025-12-31 | -$778.00K S-4/A · filed 2026-06-03 | ||||
| 2025-06-30 | -$214.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | -$538.00K 10-Q · filed 2026-08-13 | -$1.08M derived: sum of 3 quarters · filed 2026-08-13 | -$1.59M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$324.00K S-4/A · filed 2026-06-03 | -$868.00K derived: sum of 2 quarters · filed 2026-06-03 | -$1.37M derived: sum of 3 quarters · filed 2026-06-03 | -$1.99M derived: sum of 4 quarters · filed 2026-06-03 | |
| 2024-12-31 | -$544.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | -$1.05M derived: sum of 2 quarters · filed 2026-06-03 | -$1.67M derived: sum of 3 quarters · filed 2026-06-03 | -$2.44M S-4/A · filed 2026-06-03 | |
| 2024-09-30 | -$506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.12M derived: sum of 2 quarters · filed 2025-08-14 | -$1.90M 10-Q · filed 2024-11-07 | -$2.15M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-06-30 | -$616.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.39M 10-Q · filed 2025-08-14 | -$1.65M derived: sum of 3 quarters · filed 2025-08-14 | -$1.65M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$777.00K 10-Q · filed 2025-05-08 | -$1.03M derived: sum of 2 quarters · filed 2025-05-08 | -$1.03M derived: sum of 3 quarters · filed 2025-05-08 | -$1.03M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$255.00K derived: sum of 2 quarters · filed 2025-03-06 | -$255.00K derived: sum of 3 quarters · filed 2025-03-06 | -$255.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | ||||
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.60M derived: sum of 2 quarters · filed 2023-03-14 | $1.70M derived: sum of 3 quarters · filed 2023-03-14 | $1.80M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-10 | $1.70M derived: sum of 2 quarters · filed 2021-11-10 | $1.80M 10-Q · filed 2021-11-10 | $2.00M derived: sum of 4 quarters · filed 2022-03-17 | |
| 2021-06-30 | $100.00K 10-Q · filed 2021-08-12 | $200.00K 10-Q · filed 2021-08-12 | $400.00K derived: sum of 3 quarters · filed 2022-03-17 | $500.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2021-03-31 | $100.00K 10-Q · filed 2021-05-06 | $300.00K derived: sum of 2 quarters · filed 2022-03-17 | $400.00K derived: sum of 3 quarters · filed 2022-03-17 | $500.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $300.00K derived: sum of 2 quarters · filed 2022-03-17 | $400.00K derived: sum of 3 quarters · filed 2022-03-17 | $500.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-10 | $200.00K derived: sum of 2 quarters · filed 2021-11-10 | $300.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-12 | $200.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-06 | $94.00K 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $100.00K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |